SB3-G31-BC
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SB3-G31-BC, covering 2024-02-02 to 2024-02-02. Get the full timeline:
Most recent: Clinical Trial Update: A Long-term Follow-up Study for Cardiac Safety in the Patients With HER2 (+) Breast Cancer Who Have Completed the SB3-G31-BC